Aevi Genomic Medicine (Formerly Known As Medgenics)
435 Devon Park Drive
Suite 715
Wayne
Pennsylvania
19087
United States
Tel: 610-254-4201
Website: http://www.aevigenomics.com/
193 articles about Aevi Genomic Medicine (Formerly Known As Medgenics)
-
Medgenics, Inc. Extends Collaboration with Baxter Healthcare Corporation on Development of Factor VIII Biopump
7/6/2011
-
Medgenics, Inc. Comments on Market Trading Activity
6/24/2011
-
Leading Biotechnology Entrepreneur and Investor Isaac Blech Joins Medgenics, Inc. Board of Directors
6/8/2011
-
Medgenics, Inc. to Present at the 10th Annual ILSI Biomed 2011 Conference
5/19/2011
-
Medgenics, Inc. Announces Significant Shareholders Update
5/5/2011
-
Medgenics, Inc. Announces Additional Exercise by Underwriters of Over-Allotment Option
5/3/2011
-
Medgenics, Inc. Announces Exercise by Underwriters of Over-Allotment Option
4/20/2011
-
Medgenics, Inc. Announces Pricing of U.S. Initial Public Offering
4/8/2011
-
Medgenics, Inc. CEO to Present at Rodman & Renshaw Annual Global Investment Conference
9/14/2010
-
Medgenics, Inc.: 2009 Preliminary Results
5/5/2010
-
Medgenics, Inc. Signs Development Agreement with Major International Pharma Company
10/23/2009
-
Medgenics, Inc. 2009 Interim Results
9/30/2009
-
Medgenics, Inc. to Present at the Rodman & Renshaw Annual Global Investment Conference in New York
9/3/2009
-
Medgenics, Inc. Announces Patient Nearing Unprecedented 11 Months of Anemia Relief in Clinical Trial From Single Treatment of Biopump Tissue Technology; News Follows Significant Interest of Strategic Partner for New Application
8/27/2009
-
Medgenics, Inc. CEO to Present EPODURE at BioMed Conference
6/10/2009
-
Medgenics, Inc. Requests Stockholder Action in Connection with Fund Raising Through the Proposed Issue of Convertible Debentures
5/11/2009
-
Medgenics, Inc.’s Phase I/II Clinical Trial Now Shows EPODURE Continuous Anemia Treatment Lasting 5 Months in Kidney Disease Patients
3/27/2009
-
Medgenics, Inc.'s Phase I/II Clinical Trial Now Shows EPODURE Continuous Anemia Treatment Lasting 5 Months in Kidney Disease Patients
3/27/2009
-
Medgenics, Inc. Announces Positive Data from Phase I/II Clinical Trial of EPODURE Treatment of Anemia in Chronic Kidney Disease
2/3/2009
-
Medgenics, Inc. Announces Positive Data From Phase I/II Clinical Trial of EPODURE Treatment of Anemia in Chronic Kidney Disease
2/3/2009